Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.
Publication
, Journal Article
Wang, A; Bashore, TM
Published in: Eur Heart J
September 1997
Duke Scholars
Published In
Eur Heart J
DOI
ISSN
0195-668X
Publication Date
September 1997
Volume
18
Issue
9
Start / End Page
1364 / 1365
Location
England
Related Subject Headings
- Vasodilator Agents
- Hypertension, Pulmonary
- Humans
- Hemodynamics
- Epoprostenol
- Cardiovascular System & Hematology
- Antihypertensive Agents
- Administration, Inhalation
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wang, A., & Bashore, T. M. (1997). Nebulized prostacyclin for pulmonary hypertension: a step in the right direction. Eur Heart J, 18(9), 1364–1365. https://doi.org/10.1093/oxfordjournals.eurheartj.a015457
Wang, A., and T. M. Bashore. “Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.” Eur Heart J 18, no. 9 (September 1997): 1364–65. https://doi.org/10.1093/oxfordjournals.eurheartj.a015457.
Wang A, Bashore TM. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction. Eur Heart J. 1997 Sep;18(9):1364–5.
Wang, A., and T. M. Bashore. “Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.” Eur Heart J, vol. 18, no. 9, Sept. 1997, pp. 1364–65. Pubmed, doi:10.1093/oxfordjournals.eurheartj.a015457.
Wang A, Bashore TM. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction. Eur Heart J. 1997 Sep;18(9):1364–1365.
Published In
Eur Heart J
DOI
ISSN
0195-668X
Publication Date
September 1997
Volume
18
Issue
9
Start / End Page
1364 / 1365
Location
England
Related Subject Headings
- Vasodilator Agents
- Hypertension, Pulmonary
- Humans
- Hemodynamics
- Epoprostenol
- Cardiovascular System & Hematology
- Antihypertensive Agents
- Administration, Inhalation
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology